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The family of leucocyte common antigen (LCA) transmembrane glycoproteins is
expressed in most hematopoietic cells. Molecular isoforms of the LCA molecule are
generated by alternative splicing of a single gene encoded on the murine chromosome 1.
Three LCA alleles with different antigenic reactivities have been identified in inbred
mouse strains. To investigate the divergence between alleles, cDNA clones to the SJA
(Ly5a) LCA gene have been isolated and sequenced..A comparison of this information to
the Ly5
b allele sequence identifies 12 allele-specific nucleotide changes. These base
substitutions correspond to five amino-acid changes within the extracellular domain of
the LCA molecule. These amino-acid differences are clustered in a region that also
contains the greatest divergence between mouse and rat LCA sequences. Thus, these
two mouse LCA alleles exhibit a pattern of sequence conservation that mimics that
found over a much broader scale of evolution. Analysis of antigenicity profiles for each
of the allelic sequence changes reveals three molecular domains of altered antigenicity
that could account for observed serological differences between the two alleles.
Sequence information from the 5’ end of the Ly5 LCA gene, generated using
polymerase chain-reaction techniques on genomic DNA, reveals eight additional
nucleotide differences between the Ly5 and Ly5
b alleles.
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INTRODUCTION
The leucocyte common antigen family of glyco-
proteins is abundantly expressed on the surface
of most cells in .the hematopoietic lineage (Scheid
and Triglia, 1979; Sarmiento et al., 1982). These
antigens (also known as CD45, Ly5, T200, and
B220) have been identified in mouse, rat, chicken,
and human systems (Komuro et al., 1975; Fabre
and Williams, 1977; Judd et al., 1980; Omary et
al., 1980; Houssaint et al., 1987). Data from the
analysis of cDNA clones indicate that the murine
LCA molecule has a hydrophobic leader
sequence, an N-terminal extracellular domain
consisting of 402-.541 amino acids, a single trans-
membrane region, and a large cytoplasmic
domain of 705 residues (Saga et al., 1986, with a
correction, 1987; Thomas et al., 1987). The map-
ping of this family as a single gene on the mouse
chromosome 1 has been completed and shown to
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comprise 34 exons (Saga et al., 1988); exons la
and lb are alternatively excluded 5’ untranslated
sequences of LCA mRNAs, and exons 2-33 are
protein-encoding. The function of the leucocyte
common antigen has not been determined,
although its involvement in leucocyte activities,
such as natural killer cytolysis (Sparrow and
McKenzie, 1983), cytotoxic T-cell cytolysis (Harp
et al., 1984), as well as lymphocyte activation and
differentiation (Yakura et al., 1986; Mittler et al.,
1987; Pingel and Thomas, 1989) has been impli-
cated. These roles may be mediated through the
tyrosine phosphatase activity shown to be associ-
ated with the LCA molecule (Tonks et al., 1988).
In the mouse, the LCA molecule shows hetero-
geneity in molecular weight, glycosylation, and
antigenicity patterns. Differences in LCA family
members have been traced to the alternative
splicing of exons 4, 5, and 6, which generates
multiple molecular isoforms (Saga et al., 1987;
Thomas et al., 1987). In B lymphoid cells, the
major LCA protein product is 220,000 m.w. and
contains all three of these alternative exons,
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whereas the major thymocyte protein is 180,000
m.w. and does not include exons 4, 5, or 6. These
differences account for an insertion of 139 resi-
dues in the extracellular domain of the B-cell
expressed LCA molecule. Proteins of intermedi-
ate size have been observed, which apparently
represent splice combinations of exons 4, 5, and 6
(Chang et al., 1989). Glycosylation differences in
the LCA protein family are also due to the
inclusion of these variable exon sequences as the
inserted amino acids contain many serine and
threonine residues potentially linked to O-type
carbohydrate structures (Childs et al., 1983; John-
son et al., 1989).
Murine LCA glycoproteins bear the Ly5 allo-
antigenic determinant, which has been charac-
terized in both inbred and wild strains of mice
(Seldin et al., 1987). Inbred mice have been cate-
gorized into three LCA alleles, Ly5a, Ly5b, and
Ly5c, which can be distinguished antigenically by
their reactivity with specific monoclonal and
alloantibodies (Ly5.1, Ly5.2) and genetically by
RFLPs of mouse genomic DNA (Seldin et al.,
1987). Most established murine strains express
the Ly5
b allele, including BALB/c, C57BL,
CBA/J, and NZB/BLNJ, yet SJL/J mice carry the
Ly5 allele.
To examine the differences between the murine
Ly5 and Ly5
b alleles, we have isolated and ana-
lyzed cDNA clones from the Ly5 leucocyte com-
mon antigen allele. The differences between the
two alleles provide a view through a narrow win-
dow of evolution at this locus, much narrower
than that afforded by interspecies comparisons.
The highly conserved as well as the more vari-
able regions of the murine LCA molecules
address the issues of functional importance and
structural tolerance of these regions. The com-
parison also provides a better understanding of
the antigenic differences that originally defined
the alleles.
MATERIALS AND METHODS
Library Construction and Screening
Activated B and T cells were obtained by stimul-
ating SJL/J.BALB/c-IgH (SJA) mouse spleen
cells at 106 cells/ml in RPMI 1640 medium, 10%
fetal calf serum separately with LPS (25 tg/ml)
or Con A (2 tg/ml). After 2 days in culture, cells
were used to prepare poly A+ cytoplasmic RNA,
as described previously (DeCino et al., 1988). A
cDNA library was prepared using a mixture of
activated SJA B- and T-cell mRNA according to
standard procedures. First-strand synthesis was
primed with a mixture of oligo dT12-15 and ran-
dom primers. Double-stranded fragments were
prepared and cloned into the Lambda Zap II vec-
tor system (Stratagene Cloning Systems) using
EcoRI linkers. Phage were grown, amplified, and
screened according to procedures developed by
the manufacturer. Positive phage were identified
using synthetic oligonucleotides (Genetic
Designs, Inc.) corresponding to the following
nucleotide numbers of the Ly5
b cDNA sequence
(Saga et al., 1986, with a correction, 1987): oligon-
ucleotide #18, 81-111; #19, 394-434; #7,
1426-1446; #10, 2784-2802; #17, 4563-4584.
DNA Sequencing and Analysis
Purified phage were excised as pBluescript plas-
mids using procedures developed by the manu-
facturer (Stratagene) and confirmed to contain
LCA sequences by restriction enzyme mapping
and hybridization with the LCA-specific oligonu-
cleotides described before. Plasmid. DNA was
purified on cesium-chloride density gradients
(Ausubel et al., 1989) and sequenced by a modi-
fied dideoxy-chain-termination method (US
Biochemicals) using Bluescript plasmid-specific
primers and internal primers generated to the
Ly5
b LCA cDNA sequence (Saga et al., 1986, with
a correction, 1987; Raschke, 1987).
Organization of the resulting DNA sequences
and computer analysis was done on the Salk
Institute VAX using University of Wisconsin
Genetics Computer Group (UWGCG) programs
(Devereux et al., 1984; Gribskov et al., 1986).
Polymerase Chain Reaction
Cloned BALB/cke (Raschke, 1987) and SJA LCA
cDNA samples were subjected to amplification
by polymerase chain-reaction (PCR) procedures
(Saiki et al., 1988) using a Perkin-Elmer Cetus
DNA thermocycler and LCA-specific oligonucle-
otides. Messenger RNA prepared from Con A-
stimulated SJA cells was copied using reverse
transcriptase for 60 min at 37C with specific
antisense LCA primers, as described (Rappolee et
al., 1989). Both plasmid (0.25fig) and cDNAMOUSE LCA ALLELES 245
samples (from 0.33 fig mRNA) were amplified for
35 PCR cycles in the presence of 1.5 U Taq poly-
merase (Perkin-Elmer Cetus), 250 ng each primer,
200/,tM each dNTP in lx buffer (50 mM KC1,
10mM Tris, pH 8.3, 1.5mM MgC12, and
0.1 mg/ml gelatin). One PCR cycle consisted of
the following incubations: 30 sec at 94C, 1 min at
50C, and 5 min at 70C. PCR products were
extracted with phenol and chloroform, ethanol
precipitated, treated with appropriate restriction
enzymes, and separated by electrophoresis on 2%
NuSieve, 1% agarose gels (FMC Corporation).
For Southern blotting, DNA was transferred from
the gel to ZetaProbe membranes (Bio-Rad) by
capillary action in 0.4M NaOH according to the
manufacturer’s instructions. Membranes were
probed with /Pap-ATP-labeled LCA oligonucleot-
ides using ZetaProbe procedures and exposed to
Kodak X-Omat film.
For cloning PCR-amplified genomic sequences,
DNA was purified from SJL/J mouse blood
samples as described (Ausubel et al., 1989) and
amplified using LCA-specific oligonucleotides
G44 and #46 (nucleotides 1-25 and 824-858,
respectively, from Saga et al., 1988) as described
before. Synthesis of the predicted 859-bp frag-
ment was confirmed by agarose gel electro-
phoresis, and a portion (1/5) of the sample was
reamplified by PCR. Following sample separ-
ation on an agarose gel, the 850-bp fragment was
electroeluted, purified on a NACS column
(Bethesda Research Laboratories), and kinased
according to standard procedures (Ausubel et al.,
1989). For cloning and sequencing of the genomic
SJL fragment, the DNA was blunt-end ligated
into the EcoRV site of the pBluescript vector poly,
linker (Stratagene Cloning Systems) and repli-
cated in bacteria to prepare plasmid DNA. Sequ-
encing of insert DNA was done as described
before using Bluescript and LCA-specific
primers.
RESULTS
Nucleotide and Predicted Amino-Acid
Sequence of the Ly5" Leucocyte Common
Antigen
To clone the leucocyte common antigen
sequences corresponding to the murine Ly5
allele, a cDNA library to mRNA extracted from
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FIGURE 1. Clone organization of SJA leucocyte common antigen cDNAs. The cDNA clones selected from the SJA library are
shown schematically as aligned with the B-cell Ly5 cDNA sequence (Saga et al., 1986, with a correction, 1987; Thomas et al.,
1987). The oligonucleotides used for the clone selection (#18, 19, 7, 10, 17) and several restriction-enzyme cleavage sites (B, BamHI;
H, HindIII; E, EcoRI; X, XbaI) are indicated.246 S.L. ZEBEDEE et al.
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Comparison of Ly5 and Ly5 Sequence Changes
Nucleotide Nucleotide Amino-acid
position Ly5b LY5 position
TABLE 1
Residue Protein Enzyme cleavage
domain
Ly5 Ly5 Ly5 Ly5
943 A G 277 K E Extracellular
1238 T C 375 V A Extracellular SfaNI
1251 G T 379 E D Extracellular Sau3A
1252 T C 380 S P Extracellular Hinfl
1461 G A 449 Extracellular HpaII
1472 A C 453 N T Extracellular
2328 G A 738 Cytoplasmic XhoI
2589 T C 825 Cytoplasmic KpnI
3993 C A 3’ untranslated
4081 T 3’ untranslated
4139 G 3’ untranslated
4490 G 3’ untranslated
Nucleotide position corresponding with the first nucleotide of exon 2 as number 1.
bFor nucleotide differences in the 5’ untranslated region, see Fig. 4. No nucleotide changes for the Ly5 and Ly5 alleles were
observed in the predicted signal or transmembrane regions.
mitogen-stimulated SJA mouse spleen cells was
prepared. The cDNA clones were inserted into
lambda phage system vectors (see Materials and
Methods) and screened with oligonucleotide
probes derived from the published Ly5
b sequence
(Saga et al., 1986, with a correction, 1987;
Raschke, 1987). A profile of seven isolated LCA-
specific clones and the oligonucleotides used for
their screening is diagrammed in Figure 1. These
clones were subjected to nucleic-acid sequence
analysis and found to contain overlapping infor-
mation from the entire exon arrangement of the
murine LCA gene (Saga et al., 1988). Clones 871
and 271 contain information from the 5’ untrans-
lated end of the LCA gene: 871 is initiated from
exon la, whereas the 5’ end of clone 271 is from
the alternative exon lb. These clones also include
different sequence information from the alterna-
tively spliced B-cell isoform exons (Thomas et al.,
1987). Sequence from exons 4, 5, and 6 is con-
tained in clone 871; clone 271 is derived from an
alternatively processed mRNA, which is missing
these three exons.
Figure 2 shows the organized nucleotide
sequence of the overlapping Ly5 cDNAs and the
predicted amino-acid sequence generated from
the single large open reading frame. The 5’ signal
sequence (23 amino acids), single membrane-
spanning domain (22 amino acids), and orien-
tation of the protein are predicted from hydropa-
thy plots and homology with previously pub-
lished LCA sequences (Thomas et al., 1985; Saga
et al., 1986, with a correction, 1987). These com-
parisons predict a 541 residue extracellular
domain for the B-cell isoform (clone 871, as
shown in Figure 2), which contains information
for an additional 139 amino acids than the T-cell
form (clone 271, indicated by vertical marks in
Figure 2). A cytoplasmic domain of 705 amino
acids., is predicted for the murine Ly5 molecule
from these sequences.
Comparison of Ly5" and Ly5
t’ Sequences
Nucleotide differences between the SJA Ly5
cDNA sequence and the published mouse Ly5
b
sequence (Saga et al., 1986, with a correction,
1987; Raschke, 1987; Thomas et al., 1987) are also
shown in Figure 2. This sequence comparison
reveals nine single nucleotide substitutions and
three nucleotide additions in the cloned Ly5
sequence. Table 1 summarizes these nucleotide
FIGURE 2. Nucleotide sequence of the SJA leucocyte common antigen. The nucleotide sequence of the isolated SJA cDNA clones
(Ly5) as determined by dideoxy-chain-termination sequencing is shown, as is the translation into single-letter amino-acid
abbrevations. Sequence differences between the SJA Ly5 allele and the BALB/c Ly5 allele (Saga et al., 1986, with a correction,
1987; Raschke, 1987; Thomas et al., 1987) are indicated with the Ly5 difference shown directly above the Ly5 nucleotide (X
indicates no nucleotide) and are encircled. The predicted LCA-signal sequence is indicated by a line over the amino-acid
translation, the membrane-spanning region is denoted by a box, and potential asparagine-linked glycosylation sites are
underlined. The inserted 5’ B-cell sequences included in clone 871, but not in 271, are within the indicated vertical lines. For
presentation ease, the nucleic-acid sequence commences with the first nucleotide of exon 2 (Saga et al., 1988), although clones 871
and 271 contain sequence information from exons la and lb (see text and Figure 4).248 S.L. ZEBEDEE et al.
changes and the resulting amino-acid differences.
Five of the nucleotide substitutions result in an
amino-acid change of the LCA protein between
the I,y5 and Ly5
b alleles: residue 277, lysine to
glutamate; residue 375, valine to alanine, residue
379, glutamate to aspartate; residue 380, serine to
proline; and residue 453, asparagine to threonine.
As shown in Table 1, other nucleotide changes
between the two sequences either do not result in
a residue alteration, or they occur in the 3’
untranslated region of the cDNA.
All of the amino-acid differences between the
two murine LCA alleles occur in the extracellular
domain of the protein, and no changes are
observed in the transmembrane or cytoplasmic
regions. Differences in the extracellular protein
composition are amino-acid substitutions only,
and do not change any of the potential N-linked
glycosylation sites, nor do they affect the B-cell
insert exons 4, 5, and 6. One substitution, at resi-
due 277, alters the charge of the LCA protein
[lysine (+) to glutamate (--)] between Ly5 and
Ly5b. Other substitutions are conservative (valine
to alanine; glutamate to aspartate) or involve
changes in hydrophobicity and protein structure
(serine to proline; asparagine to threonine), as
indicated in Table 1.
Confirmation of Nucleotide Sequence using
PCR
Several of the nucleotide changes between the
Ly5 and Ly5
b alleles result in the loss or acqui-
sition of restriction enzyme sites, as indicated in
Table 1. To confirm these nucleotide differences,
both plasmid DNA and mRNA from both LCA
alleles were subjected to polymerase chain-reac-
tion (PCR) amplification using LCA-specific oli-
gonucleotides surrounding each change to be
tested. The amplified products from both Ly5
and Ly5
b sequences were then digested with the
restriction enzymes from Table 1 and examined
for the loss or addition of individual sites. Figure
3 shows the resulting PCR cleavage patterns for
two Ly5-specific sites: HinfI at nucleotide 1252 of
the Ly5
b sequence and KpnI at nucleotide 2589 of
Ly5b. In both cases, DNA from amplified Ly5
b
samples is digested in a predictable manner,
A,
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FIGURE 3. PCR analysis of nucleotide-sequence differences by enzyme cleavage. Nucleotide-sequence differences between Ly5
and Ly5 were detected from PCR-amplified cDNA and mRNA samples using Ly5b-specific cleavage sites for HinfI (A) at
nucleotide position 1251 and KpnI (B) at position 2589. Digestion patterns were detected from separation on agarose gels, transfer
to ZetaProbe membranes, and detection with oligonucleotide probes. (A) cDNA (lanes 1, 2, 6, 7) or mRNA (lanes 3, 4, 8, 9)
corresponding to the Ly5 (lanes 1, 3, 6, 8) or Ly5 (lanes 2, 4, 7, 9) sequence were PCR-amplified using LCA-specific
olgionucleotides at positions #1114-1131 and #1657-1669 (Fig. 2). Amplified samples were digested with HinfI (lanes 6-9) or not
treated (lanes 1-4), and probed with an LCA oligonucleotide (#1339-1358), which is predicted to detect a HinfI cleavage product
of 155 bp from the Ly5sequence or 240 bp from the Ly5 sequence. Undigested DNA is expected to yield a 555-nucleotide
fragment. Lane 5 shows a sample containing water in place of DNA or RNA subjected to PCR amplification. (B) Samples from
Ly5 cDNA (lanes 1, 5; Raschke, 1987) or mRNA (lanes 3, 7) and Ly5 mRNA (lanes 2, 6) were PCR-amplified with
oligonucleotides corresponding to nucleotides #2531-2567 and #3167-3186 of LCA sequences (Fig. 2). The resulting KpnI
digestion of these samples (lanes 5-7) and detection with an internal oligonucleotide (#2955-2979) are shown. Only the Ly5
sequence is predicted to produce a PCR product that can be cleaved from 652 bp to 599 bp with KpnI. Lane 4 shows a sample
containing water in place of DNA or RNA subjected to PCR amplification.MOUSE LCA ALLELES 249
TABLE 2
Structural and Antigenic Comparison of Altered Ly5 and Ly5 Domains
Position Amino-acid residue Chou-Fasman prediction Antigenicity index
Ly5 Ly5 Ly5 Ly5 Ly5 Ly5
275 K K h h 0.900
276 T T h h 0.900
277* E K h h 0.900
278 N N h h 0.900
279 L L h h 0.750
280 D D h h 1.150
371 W W B B 0.300
372 P P 0.800
373 E E 1.100
374 p p 1.300
375* A V 1.500
376 S S 1.100
377 K K 0.900
378 P P T 1.300
379* D E T 1.300
380* P S T 1.300
381 A A T 1.300
382 S S 1.100
450 D D T T 1.300
451 K K h 0.900
452 V V h 0.750
453* T N h 0.750
454 G G h 0.750
455 M M h 0.600
456 K K h 0.900
457 T T 0.900
0.900
1.300
1.300
1.300
1.150
1.150
0.300
0.650
0.950
0.900
0.900
0.900
0.900
1.100
1.100
0.900
1.100
1.100
1.300
0.900
0.950
1.500
1.150
1.000
0.900
0.900
aAltered amino-acid positions between Ly5 and Ly5 are indicated by an asterisk (*).
bChou and Fasman, 1978 h=helix, B=sheet, and t, T=turn regions, with T>t for strength of prediction.
Cjameson and Wolf, 1988.
whereas Ly5 sequences are not cleaved at these
specific sites (Figure 3). Similarly, an analysis of
amplified DNA from LCA clones and mRNA at
the other enzyme sites (e.g., SfaNI, Sau3A, HpaII,
and XhoI) also resulted in the appropriate frag-
ment digestion patterns (data not shown). Thus,
the nucleotide sequence differences between
these two LCA alleles at 6 of the 12 altered sites
have been confirmed.
Antigenic Analysis of LCA Allele Differences
To examine the correlation between the observed
molecular differences in amino-acid sequence
and the antigenic variation of the Ly5 and Ly5
b
proteins, a computer analysis of antigenicity was
performed. The amino-acid sequence corre-
sponding to the extracellular and membrane-
spanning domains of each LCA molecule was
examined for alterations in the antigenic index
(Jameson and Wolf, 1988), which includes for
each amino-acid residue measurements of hydro-
phobicity, surface probability, flexibility, and sec-
ondary structure. The resulting data indicate sig-
nificant differences in antigenicity (values >1.2)
between the Ly5 and Ly5
b leucocyte common
antigen alleles across the regions of amino-acid
change (Table 2). A comparison of the corre-
sponding figures for Chou-Fasman predictions
(Chou and Fasman, 1978) and antigenic index
(Jameson and Wolf, 1988) reveals three domains
of altered antigenicity and structure around the
following amino acids: residue 277, increased
antigenicity of the Ly5
b protein; residues 375-380,
increased antigenicity and structural alteration of
Ly5a; and residue 453, increased antigenicity and
predicted structural change of the Ly5
b molecule.
Nucleotide Sequence of Ly5" Genomic DNA
The isolated SJA cDNA clones contain a portion
of the complete sequence information available
for the Ly5
b exons la and lb sequence (Saga et al.,
1988). To obtain the remaining nucleotide250 S.L. ZEBEDEE et al.
oligo G44
IO0
L-..Exonla
clone 871 End a
300
400
TG T
501 TGAATTAAGGAAGTAAGAAGccATTGcAcTGAcTTTGAAcGAccTTTTTTTTTTTTTTTTTAAcTTccTGcAAAGAGGAcccTTTACAGTATTTTTGGAG 600
ill
x v
601 AAGTTAGTAAAACCGAATCTGACATCACCATTTAGCAGTGCATGTAGCTAGCAAGTGGTTTGTTCTTAGGGTAAGAGAGTAGGAAACTTGCTCCCCATCT 700 L_>, Exon b
G
701 GATAAGACAGAGTGCAAAGTATGCGTTCTTTTCTTTTAGTTTTGACTTAGCTTTACAGAGACAAACTTCAAGAGAGATAACCATTATTTTGCCTTTCAGG 800
clone 271 End lb
801 GAGACCCTATTTCTTAGGGGCACACTGATCTCCAGATATGACCATGGGTTTGTGGCTC 859
Exon 2 Oligo #46
FIGURE 4. Nucleotide sequence of SJL/J genomic DNA including exons la and lb. The nucleotide sequence of the fragment
generated by PCR using SJL genomic DNA and the G44 and #46 oligonucleotides is shown. Differences with the Ly5 sequence
(Saga et al., 1988) are indicated above the Ly5 sequence (X indicates no nucleotide). The LCA-specific oligonucleotides used for
fragment generation (G44, #46) are boxed, and the information obtained from cDNA library isolated clones (871, 271) is
underlined. The start and end of exons la and lb sequences (Saga et al., 1988) are shown. The start of exon 2 is also indicated and
corresponds to the beginning of the cDNA sequence shown in Fig. 2. Oligonucleotide 46 lies within exon 2. The string of
thymidines that showed some variation in length between individual clones of PCR generated fragments is indicated by a heavy
underline.
sequence from the 5’ end of the LCA mRNA mol-
ecules and to examine the potential transcription
regulatory sequences, a genomic fragment that
includes exons la and lb sequences was gener-
ated from Ly5 DNA using PCR techniques. Gen-
omic DNA was isolated from SJL/J (Ly5a) blood
samples and amplified using LCA oligonucleot-
ides G44 and #46 prepared to the Ly5
b published
sequence at the 5’ gene end (Figure 4; Saga et al.,
1988). The nucleotide sequence of the resulting
859-.bp PCR product is shown in Figure 4 as com-
pared to the Ly5
b genomic sequence. Eight nucle-
otide differences in this region of the LCA gene
have been identified between these two murine
alleles. Two changes affect the sequence of exon
lb: an insertion of a T at position 41, and a
deletion of an A at position 64 of the exon lb Ly5
sequence. As indicated in Figure 4, cDNA clone
271 does not extend far enough to detect these
changes in exon lb. Six other nucleotide differ-
ences are present between the BALB/c and SJL
LCA genomic fragment, yet none of these
changes is expected to affect LCA gene regulat-
ory TATA-like sequences (Saga et al., 1988), gene
splicing, or coding arrangements. This PCR-gen-
erated Ly5 genomic sequence was confirmed
from separate fragments isolated from indepen-
dent amplification reactions, with the exception
of one stretch of 17 thymidines in the intron
between exons la and lb. Several of the individu-
ally cloned PCR fragments contained 15 or 16
thymidines, indicating a tendency of the amplifi-
cation reaction to unfaithfully reproduce
stretches of identical nucleotides. Although the
possibility exists that the Ly5 gene has fewer
than 17 thymidines in this location, the sequenceMOUSE LCA ALLELES 251
shown in Figure 4 with 17 thymidines was found
in the majority of the fragments analyzed.
DISCUSSION
The nucleotide and amino-acid sequence of the
leucocyte common antigen from a second murine
allele (Ly5a) is reported. A comparison of this
cDNA sequence with that of the published Ly5
b
allele (Saga et al., 1986, with a correction, 1987;
Thomas et al., 1987) reveals 12 nucleotide
changes. Several of these nucleotide changes
cause alterations in the restriction enzyme digest
patterns of LCA cDNA (see Table 1), and these
enzymes were used to detect and confirm the
specific changes among the two alleles by PCR
using LCA-specific oligonucleotides. Five amino-
acid substitutions between Ly5 and Ly5
b result
from the allele nucleotide differences, and these
changes all occur in the extracellular domain of
the membrane-spanning LCA molecule. Interest-
ingly, this variation in the extracellular domain
of the two murine alleles parallels the homology
found among interspecies LCA molecules. The
LCA extracellular region is only about 50% simi-
lar among human, rat, and mouse LCA molecules
(Tung et al., 1988), whereas the transmembrane
and cytoplasmic regions show a higher degree of
homology among these species (80-90%). There-
fore, the same selection pressures are already evi-
dent over the short evolutionary time scale.
The accumulation of differences in the various
regions of the Ly5 gene can be considered indica-
tive of the tolerance of changes in these areas
with respect to expression of the gene or function
of the gene product. Other than the regions enco-
ding the leader sequence and the transmembrane
regions that are comparatively conserved, the
cytoplasmic domain has the lowest frequency of
differences, 0.09% (2 differences/2115 base
pairs). The extracellular domain and 3’ untrans-
lated region each have a frequency of 0.37%
(6/1623 and 4/1085, respectively). The greatest
density of differences between the Ly5 and Ly5
b
regions sequenced is at the 5’ end, where the
transcribed but untranslated sequences (exons la
and lb and part of exon 2) have a frequency of
0.75% (2/268) and the genomic, untranscribed
sequences have a frequency of 1.04% (6/576).
The significance of the greater conservation of
noncoding sequences at the 3’ end of the gene
compared to the 5’ end is not clear, although a
role for the 3’ untranslated sequence in the stab-
ility of the mRNA is possible. None of the nucleo-
tide differences in the 5’ genomic sequences of
the two alleles (Figure 4) is predicted to affect
transcript initiation or the start of translation for
this gene. It should be noted that the Ly5 gen-
omic sequence was generated from independent
clones using polymerase chain reaction tech-
niques reported to have a nucleotide incorpor-
ation-error frequency of 0.25% (Saiki et al., 1988).
In this case, the only examples of enzyme infi-
delity occurred in a stretch of 17 thymidines in
which some of the cloned PCR fragments con-
tained fewer thymidines.
Conservation of the 705 amino-acid cytoplas-
mic domain between the two mouse alleles and
among other species implies a functional import-
ance for this region of the LCA molecule. Fea-
tures of the leucocyte common antigen, including
the size and conservation of the cytoplasmic
domain, cytoplasmic phosphorylated residues
(Thomas et al., 1985; Shackelford and Trow-
bridge, 1986), cytoplasmic protein tyrosine phos-
phatase activity (Tonks et al., 1988; Ostergaard et
al., 1989), and association with the cytoskeletal
fodrin molecule (Bourguignon et al., 1985), have
led to the speculation that this family of mol-
ecules is involved in signal transduction. It has
been demonstrated that the LCA molecule regu-
lates T-cell growth (Kiener and Mittler, 1989;
Ostergaard et al., 1989; Pingel and Thomas, 1989)
through changes in molecular phosphorylation
pathways. This hematopoietic cell-growth regu-
lation may be triggered through the interaction
of LCA with different T- and B-cell receptor mol-
ecules (Ledbetter et al., 1988) or soluble ligands
as mediated by the different cell-type-specific
LCA isoforms. In this matter, the isoforms could
account for the variety of activities observed for
the LCA molecule, such as lymphocyte differen-
tiation and proliferation, T-cell cytolysis, and
natural killer activity.
The nucleotide and amino-acid differences
between the two alleles in the extracellular
domain are not evenly distributed, but occur
within a 530-bp, 177 amino-acid segment in the
second half of the domain. The first half and last
sixth of the extracellular domain are as conserved
as the cytoplasmic domain at the protein level for
these two murine Ly5 alleles. Interestingly, the
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is also the region with the most variation
between the rat (Barklay et al., 1987; Rappolee et
al., 1989) and mouse (Saga et al., 1986, with a cor-
rection, 1987; Raschke, 1987) LCA extracellular
sequences, having an amino-acid homology in
this region of 51% compared with 67% for the
remainder of the domain.
The comparison of the rat LCA sequence with
the mouse alleles reveals some interesting
relationships. Of the 12 nucleotide differences in
the cDNAs of the Ly5 alleles, the Ly5 and rat
sequences are identical at four of the positions
(nucleotides 1238, 1461, 2589, and 4092; see Fig-
ure 2 and Table 1). In another three of the pos-
itions (nucleotides 943, 1472, and 2328), the Ly5
b
nucleotide is identical to that in the rat sequence.
[Of the remaining five positions of allelic
sequence differences, two (nucleotides 1251 and
1252) are in an 18-nucleotide segment not present
in the rat and one (nucleotide 4490) is in a region
for which the rat sequence is not published.] The
amino acids encoded by these differences are also
identical between rat and the respective murine
allele, in spite of the other numerous species dif-
ferences in this region at the nucleotide and ami-
no-acid levels. Thus, at each Ly5 allelic difference
in the coding region, the corresponding rat nucle-
otide is identical to either the Ly5 or Ly5
b nucleo-
tide, with the exception of the two located in a
segment that is absent in the rat sequence. This
relationship is unlikely to be fortuitous, yet no
clear explanation based on evolutionary pro-
gression or selection is evident.
Two clones were isolated from the SJA library
with distinct 5’ sequence information from exons
la and lb, and the B-cell insert exons 4, 5, and 6.
The cDNA library was prepared to mRNA from a
mixture of mitogen-stimulated B- and T-cell
populations in order to obtain B- and T-cell
sequence information for the Ly5 allele. Various
alternative splice combinations of exons 4, 5, and
6 have been observed among LCA family mem-
bers (reviewed in Thomas and Lefrancois, 1988),
including the identification of mRNAs corre-
sponding to six of the eight possible alternatively
processed transcripts. Our screening of the Ly5
library using 5’ oligonucleotides identified only
two of these combinations: one with exons
4+5+6, and the other without any of these exons.
The association of exon 4, 5, and 6 splice patterns
with transcript initiation from exon la or lb for
the LCA molecule does not appear to be cell-
type-specific (Saga et al., 1987, 1988). In fact, the
isolated clones described contain exon la with
the B-cell insert of exons 4, 5, and 6 (clone 871)
and exon lb without exons 4, 5, and 6 (clone 271),
which is opposite of the transcript organization
that appears to be most abundant for this gene
family (Saga et al., 1988).
Determination of the amino-acid sequence for
the leucocyte common antigen Ly5 allele allows
for an examination of the alloantigenic distinc-
tions from the murine Ly5
b allele on a molecular
level. Changes in the nucleotide sequence that
result in different restriction enzyme patterns
(Table 1) for these two murine alleles can now be
used in combination with PCR techniques as an
allele-specific assay system. Previous distinctions
between these alleles have relied upon proteol-
ysis experiments, RFLP patterns, and antigenic
reactivities. Cleveland peptide maps generated
with V8 protease (Tung et al., 1981) can now be
explained by the amino-acid changes at gluta-
mate residues (see Table 1) between these two
alleles. Also, conventional Ly5 alloantisera
(prepared from the immunization of intraallelic
F1 mice with cells from the other allele; Scheid
and Triglia, 1979) and allele-specific monoclonal
antibodies (Shen, 1981) have been shown to dis-
tinguish mice carrying the Ly5 (Ly5.1 antisera) or
Ly5
b (LyS.2 antisera) alleles (Seldin et al., 1987).
Analysis of the antigenicity of the Ly5 versus
Ly5
b alleles based on the amino-acid composition
of the extracellular region highlights three major
antigenic differences at residues 276-279,
372-381, and 451-456 (Table 2). Reactivities of the
LCA alleles with alloantisera are likely to be due
to recognition differences of the amino acids and
molecular structure of these domains. The anti-
genic index for the Ly5 alIele becomes higher in
value at only one of these regions (residues
372-381, see Table 2), thus suggesting that this is
the major epitope for the Ly5.1 antibodies. The
other two allele-distinct LCA domains show
increased antigenicity of the Ly5
b allele; there-
fore, the monoclonal and alloantibody recog-
nition of this allele product is predicted to be
through one or both of these epitopes. Interest-
ingly, as both Ly5 and Ly5
b mice express an
apparently functional LCA protein, the identifi-
cation of distinct allele-specific extracellular resi-
dues suggests that these regions are not likely to
be involved in a common cell function for the
LCA molecule.MOUSE LCA ALLELES 253
Allele-specific differences in the murine leuco-
cyte common antigen have been identified from
cDNA cloning and sequence analysis. The
observed nucleotide changes between SJA (Ly5a)
and BALB/c (Ly5b) mice are predicted to be all-
ele-specific, although additional differences
between SJA and other Ly5 mice, as well as
BALB/c and other Ly5
b mice may occur.
Additional intraallelic changes are not expected
to play a role in the antigenicity differences
between the Ly5 and Ly5
b alleles. Changes in the
nucleic-acid sequence among these two alleles
can be used to categorize mouse mRNA or DNA
into Ly5 or Ly5
b subtypes using PCR and
sequence-specific restriction-enzyme cleavage
sites. The identified nucleotide-sequence changes
translate into extracellular protein domains dis-
tinguished by antibody reactivity, for which a
molecular basis is now proposed.
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